Cargando…
Neoadjuvant therapy before surgical treatment
Neoadjuvant treatment in terms of preoperative radiotherapy reduces local recurrence in rectal cancer, but this improvement has little if any impact on overall survival. Currently performed optimal quality-controlled total mesorectal excision (TME) surgery for patients in the trial setting can be as...
Autores principales: | Glynne-Jones, Rob, Chau, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041305/ https://www.ncbi.nlm.nih.gov/pubmed/26217113 http://dx.doi.org/10.1016/j.ejcsup.2013.07.032 |
Ejemplares similares
-
Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers
por: Khan, A A, et al.
Publicado: (2013) -
TNT in rectal cancer may not be the new testament?
por: Glynne-Jones, Rob
Publicado: (2019) -
Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
por: Glynne-Jones, R, et al.
Publicado: (2006) -
Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma
por: Jain, Anish J., et al.
Publicado: (2023) -
Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018)